InChI=1S/C30H52O3/c1- 19(2) 10- 9- 14- 30(8,33) 20- 11- 16- 29(7) 25(20) 21(31) 18- 23- 27(5) 15- 13- 24(32) 26(3,4) 22(27) 12- 17- 28(23,29) 6/h10,20- 25,31- 33H,9,11- 18H2,1- 8H3/t20- ,21+,22- ,23+,24- ,25- ,27- ,28+,29+,30- /m0/s1 |
PYXFVCFISTUSOO-HKUCOEKDSA-N |
CC(C) =CCC[C@] (C) (O) [C@H] 1CC[C@] 2(C) [C@@H] 1[C@H] (O) C[C@@H] 1[C@@] 3(C) CC[C@H] (O) C(C) (C) [C@@H] 3CC[C@@] 21C |
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via protopanaxadiol )
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
(via protopanaxadiol )
|
|
View more via ChEBI Ontology
(3β,12β)-dammar-24-ene-3,12,20-triol
|
(20S)-protopanaxadiol
|
UniProt
|
20(S)-APPD
|
ChemIDplus
|
20-Epiprotopanaxadiol
|
ChemIDplus
|
24-dammarene-3β,12β,20S-triol
|
LIPID MAPS
|
dammar-24-ene-3β,12β,20-triol
|
SUBMITTER
|
dammar-24-ene-3β,12β,20S-triol
|
LIPID MAPS
|
30636-90-9
|
CAS Registry Number
|
ChemIDplus
|
3086791
|
Reaxys Registry Number
|
Reaxys
|
22039120
|
PubMed citation
|
SUBMITTER
|
23006538
|
PubMed citation
|
Europe PMC
|
23022533
|
PubMed citation
|
Europe PMC
|
23183919
|
PubMed citation
|
Europe PMC
|
23391424
|
PubMed citation
|
Europe PMC
|
23407364
|
PubMed citation
|
Europe PMC
|
23494798
|
PubMed citation
|
Europe PMC
|
23633038
|
PubMed citation
|
Europe PMC
|
23672053
|
PubMed citation
|
Europe PMC
|
23724657
|
PubMed citation
|
Europe PMC
|
23867244
|
PubMed citation
|
Europe PMC
|
23877070
|
PubMed citation
|
Europe PMC
|
24096145
|
PubMed citation
|
Europe PMC
|
|